SAR_4

  • Structural Feature

    C(3) ketone reduction only

  • Impurities

    3-Deoxolevonorgestrel 13-Ethyl-3-ethynyl-18,19-dinor-17α-pregna-3,5-dien-20-yn-17-ol 13-Ethyl-3-methoxygona-2,5(10)-dien-17β-ol Methoxydienone 13-Ethyl-3-methoxy-18,19-dinor-17α-pregna-3,5-dien-20-yn-17-ol 13-Ethyl-3-methoxy-18,19-dinor-17α-pregna-2,5(10)-dien-20-yn-17-ol 13-Ethyl-3-methoxy-18,19-dinor-17α-pregna-1,3,5(10)-trien-20-yn-17-ol 13-Ethyl-3,4-diethynyl-18,19-dinor-17α-pregn-5-en-20-yn-3β,4α,17-triol 13-Ethyl-3,4-diethynyl-18,19-dinor-17α-pregn-5-en-20-yn-3α,4α,17-triol

  • References

    ×

    References

    Title Description Ref # PDF
    Besse et al. Environmental Pollution 2009 Besse, J. P.; Garric, J., Progestagens for human use, exposure and hazard assessment for the aquatic environment. Environ. Pollut. 2009, 157 (12), 3485-3494. 29
    Dore et al. Journal of Medicinal Chemistry 1986 Dore JCG, J.; Ojasoo, T.; Raynaud, J. P. CORRESPONDENCE-ANALYSIS APPLIED TO STEROID-RECEPTOR BINDING. Journal of Medicinal Chemistry. 1986; 29:54-60. 47

     

  • No modification of progestagenic activity (Besse, 2009) Decreases specificity by introducing a corticoid component

    WordPress › Error

    There has been a critical error on this website.

    Learn more about troubleshooting WordPress.